|
1
|
Gala K, Burdzińska A, Idziak M, Makula J
and Pączek L: Characterization of bone-marrow-derived rat
mesenchymal stem cells depending on donor age. Cell Biol Int.
35:1055–1062. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGinley L, McMahon J, Strappe P, Barry F,
Murphy M, O'Toole D, et al: Lentiviral vector mediated modification
of mesenchymal stem cells & enhanced survival in an in vitro
model of ischaemia. Stem Cell Res Ther. 2:122011. View Article : Google Scholar :
|
|
3
|
Dinarello CA: The role of the
interleukin-1-receptor antagonist in blocking inflammation mediated
by interleukin-1. N Engl J Med. 343:732–734. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arend WP, Malyak M, Guthridge CJ and Gabay
C: Interleukin-1 receptor antagonist: role in biology. Annu Rev
Immunol. 16:27–55. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Prockop DJ and Oh JY: Mesenchymal
stem/stromal cells (MSCs): role as guardians of inflammation. Mol
Ther. 20:14–20. 2012. View Article : Google Scholar :
|
|
6
|
Volarevic V, Al-Qahtani A, Arsenijevic N,
Pajovic S and Lukic ML: Interleukin-1 receptor antagonist (IL-1Ra)
and IL-1Ra producing mesenchymal stem cells as modulators of
diabetogenesis. Autoimmunity. 43:255–263. 2010. View Article : Google Scholar
|
|
7
|
Shi XL, Zhu W, Tan JJ, Xiao JQ, Zhang L
and Xu Q: Effect evaluation of interleukin-1 receptor antagonist
nanopar-ticles for mesenchymal stem cell transplantation. World J
Gastroenterol. 19:1984–1991. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Doughty LA, Patrene KD, Evans CH, Boggs SS
and Robbins PD: Constitutive systemic expression of IL-1Ra or
soluble TNF receptor by genetically modified hematopoietic cells
suppresses LPS induction of IL-6 and IL-10. Gene Ther. 4:252–257.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boggs SS, Patrene KD, Mueller GM, Evans
CH, Doughty LA, et al: Prolonged systemic expression of human IL-1
receptor antagonist (hIL-1ra) in mice reconstituted with
hematopoietic cells transduced with a retrovirus carrying the
hIL-1ra cDNA. Gene Ther. 2:632–638. 1995.PubMed/NCBI
|
|
10
|
Zhang X, Zhang C, Tang T, Qu Z, Lou J and
Dai K: Immunomodulatory and osteogenic differentiation effects of
mesenchymal stem cells by adenovirus-mediated coexpression of
CTLA4Ig and BMP2. J Orthop Res. 26:314–321. 2008. View Article : Google Scholar
|
|
11
|
Amendola M, Venneri MA, Biffi A, Vigna E
and Naldini L: Coordinate dual gene transgenesis by lentiviral
vectors carrying synthetic bidirectional promoters. Nat Biotechnol.
23:108–116. 2005. View
Article : Google Scholar
|
|
12
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Laitala-Leinonen T: Unsatisfactory gene
transfer into bone-resorbing osteoclasts with liposomal
transfection systems. J Negat Results Biomed. 4:5–13. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Beyth S, Schroeder J and Liebergall M:
Stem cells in bone diseases: current clinical practice. Br Med
Bull. 99:199–210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Devine MJ, Mierisch CM, Jang E, Anderson
PC and Balian G: Transplanted bone marrow cells localize to
fracture callus in a mouse model. J Orthop Res. 20:1232–1239. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang L, Li Y, Chen J, Gautam SC, Zhang Z,
Lu M, et al: Ischemic cerebral tissue and MCP-1 enhance rat bone
marrow stromal cell migration in interface culture. Exp Hematol.
30:831–836. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiang J, Tang J, Song C, Yang Z, Hirst DG,
Zheng QJ, et al: Mesenchymal stem cells as a gene therapy carrier
for treatment of fibrosarcoma. Cytotherapy. 11:516–526. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Quarto R, Mastrogiacomo M, Cancedda R,
Kutepov SM, Mukhachev V and Lavroukov A: Repair of large bone
defects with the use of autologous bone marrow stromal cells. N
Engl J Med. 344:385–386. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Horwitz EM, Gordon PL, Koo WK, Marx JC,
Neel MD and McNall RY: Isolated allogeneic bone marrow-derived
mesen-chymal cells engraft and stimulate growth in children with
osteogenesis imperfecta: implications for cell therapy of bone.
Proc Natl Acad Sci USA. 99:8932–8937. 2002. View Article : Google Scholar
|
|
20
|
Chen SL, Fang WW, Ye F, Liu YH, Qian J and
Shan SJ: Effect on left ventricular function of intracoronary
transplantation of autologous bone marrow mesenchymal stem cell in
patients with acute myocardial infarction. Am J Cardiol. 94:92–95.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oh JY, Roddy GW, Choi H, Lee RH, Ylöstalo
JH, Rosa RH, et al: Anti-inflammatory protein TSG-6 reduces
inflammatory damage to the cornea following chemical and mechanical
injury. Proc Natl Acad Sci USA. 107:16875–16880. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi H, Lee RH, Bazhanov N, Oh JY and
Prockop DJ: Anti-inflammatory protein TSG-6 secreted by activated
MSCs attenuates zymosan-induced mouse peritonitis by decreasing
TLR2/NF-κB signaling in resident macrophages. Blood. 118:330–338.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo Z, Li H, Li X, Yu X, Wang H, Tang P,
et al: In vitro characteristics and in vivo immunosuppressive
activity of compact bone-derived murine mesenchymal progenitor
cells. Stem Cells. 24:992–1000. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu S, De Becker A, Van Camp B,
Vanderkerken K and Van Riet I: An improved harvest and in vitro
expansion protocol for murine bone marrow-derived mesenchymal stem
cells. J Biomed Biotechnol. 2010:1059402010. View Article : Google Scholar :
|
|
25
|
Cheng CC, Lian WS, Hsiao FS, Liu IH, Lin
SP, Lee YH, et al: Isolation and characterization of novel murine
epiphysis derived mesenchymal stem cells. PloS One. 7:e360852012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gao Z, Golob J, Tanavde VM, Civin CI,
Hawley RG and Cheng L: High levels of transgene expression
following transduction of long-term NOD/SCID-repopulating human
cells with a modified lentiviral vector. Stem Cells. 19:247–259.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peister A, Mellad JA, Larson BL, Hall BM,
Gibson LF and Prockop DJ: Adult stem cells from bone marrow (MSCs)
isolated from different strains of inbred mice vary in surface
epitopes, rates of proliferation and differentiation potential.
Blood. 103:1662–1668. 2004. View Article : Google Scholar
|
|
28
|
Guo Z, Li H, Li X, Yu X, Wang H, Tang P,
et al: In vitro characteristics and in vivo immunosuppressive
activity of compact bone-derived murine mesenchymal progenitor
cells. Stem Cells. 24:992–1000. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dinarello CA: Biologic basis for
interleukin-1 in disease. Blood. 87:2095–2147. 1996.PubMed/NCBI
|
|
30
|
He T, Wu W, Huang Y, Zhang X, Tang T and
Dai K: Multiple biomarkers analysis for the early detection of
prosthetic aseptic loosening of hip arthroplasty. Int Orthop.
37:1025–1031. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Campion GV, Lebsack ME, Lookabaugh J,
Gordon G and Catalano M: Dose-range and dose-frequency study of
recombinant human interleukin-1 receptor antagonist in patients
with rheumatoid arthritis. The IL-1Ra Arthritis Study Group.
Arthritis Rheum. 39:1092–1101. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ortiz LA, Dutreil M, Fattman C, Pandey AC,
Torres G, Go K, et al: Interleukin 1 receptor antagonist mediates
the antiinflammatory and antifibrotic effect of mesenchymal stem
cells during lung injury. Proc Natl Acad Sci USA. 104:11002–11007.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu H, Lu W and Mahato RI: Mesenchymal stem
cells as a gene delivery vehicle for successful islet
transplantation. Pharm Res. 28:2098–2109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Löw K, Blesch A, Herrmann J and Tuszynski
MH: A dual promoter lentiviral vector for the in vivo evaluation of
gene therapeutic approaches to axon regeneration after spinal cord
injury. Gene Ther. 17:577–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng YB, Zhang XH and Huang ZL:
Amniotic-fluid-derived mesenchymal stem cells overexpressing
interleukin-1 receptor antagonist improve fulminant hepatic
failure. PLoS One. 7:e413922012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dozza B, Di Bella C, Lucarelli E,
Giavaresi G, Fini M, Tazzari PL, et al: Mesenchymal stem cells and
platelet lysate in fibrin or collagen scaffold promote non-cemented
hip prosthesis integration. J Orthop Res. 29:961–968. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ramnaraine ML, Mathews WE and Clohisy DR:
Lentivirus transduction of human osteoclast precursor cells and
differentiation into functional osteoclasts. Bone. 50:97–103. 2012.
View Article : Google Scholar
|
